Molecular imaging in nuclear cardiology.
暂无分享,去创建一个
[1] F. Blankenberg,et al. Small is beautiful: Specialty imaging devices and the growth of nuclear cardiology , 2000, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[2] D. Harats,et al. Imaging of Aortic Atherosclerotic Lesions by 125I-LDL, 125I-Oxidized-LDL, 125I-HDL and 125I-BSA , 2002, Pathobiology.
[3] J. Pickard,et al. Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.
[4] Ignasi Carrió,et al. Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[5] Akira Kitabatake,et al. Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: A study using oxygen 15-labeled water PET , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[6] J. Witztum,et al. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo , 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[7] R. Bailly. A New Tool for Infrared Studies. , 1948, Science.
[8] D. Cokkinos,et al. Effect of plaque burden on coronary vasoreactivity in early atherosclerosis. , 1998, The American journal of cardiology.
[9] A. Quyyumi,et al. Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.
[10] Robert A. Kloner,et al. Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution , 2003, Circulation.
[11] J. Isner,et al. Arterial Gene Therapy for Restenosis. St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts , 1996 .
[12] M. Schwaiger,et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. , 1993, Journal of the American College of Cardiology.
[13] F. Strutz,et al. Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[14] N. Magosaki,et al. Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium dependent vasoreactivity of the coronary microcirculation , 2003, Heart.
[15] A. Fischman,et al. Imaging Human Atherosclerosis with 99mTc‐labeled Low Density Lipoproteins , 1988, Arteriosclerosis.
[16] P. Stone,et al. Randomized trial of a medical food for the dietary management of chronic, stable angina. , 2002, Journal of the American College of Cardiology.
[17] J. Shaw,et al. THE DIRECT DIAGNOSIS OF MYOCARDIAL INFARCTION BY PHOTOSCANNING AFTER ADMINISTRATION OF CESIUM-131. , 1964, American heart journal.
[18] A M Lees,et al. External imaging of human atherosclerosis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] P. Angelberger,et al. Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy , 1993, European Journal of Nuclear Medicine.
[20] M. Takeya,et al. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals , 2002, Medical Electron Microscopy.
[21] C. Claussen,et al. Tc-99m-labeled endothelin derivative for imaging of experimentally induced atherosclerosis. , 2001, Atherosclerosis.
[22] O Muzik,et al. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] A. Alavi,et al. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. , 2002, Seminars in nuclear medicine.
[24] R. Lees,et al. Technetium-99m low density lipoproteins: preparation and biodistribution. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] Bernard J. Gersh,et al. Chronic coronary artery disease , 2001 .
[26] R. Hendel,et al. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. , 2000, Circulation.
[27] Christodoulos Stefanadis,et al. Thermal heterogeneity in stable human coronary atherosclerotic plaques is underestimated in vivo: the "cooling effect" of blood flow. , 2003, Journal of the American College of Cardiology.
[28] K. Gould,et al. Coronary flow reserve as a physiologic measure of stenosis severity. , 1990, Journal of the American College of Cardiology.
[29] T. K. Natarajan,et al. A scintiphotographic method for measuring left ventricular ejection fraction in man without cardiac catheterization. , 1971, The American journal of cardiology.
[30] H. Strauss,et al. Radiotracer characterization of coronary artery lesions. , 2002, Nuclear medicine communications.
[31] W. Blahd. Ben Cassen and the development of the rectilinear scanner. , 1996, Seminars in nuclear medicine.
[32] B. Gmeiner,et al. Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy , 1993, European Journal of Nuclear Medicine.
[33] A. Fischman,et al. Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] T. K. Natarajan,et al. A noninvasive scintiphotographic method for detecting regional ventricular dysfunction in man. , 1971, The New England journal of medicine.
[35] J. Isner,et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. , 1998, Circulation.
[36] J. Barrio,et al. C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. IV. In vivo evaluation of acute demand-induced ischemia in dogs. , 1983, American heart journal.
[37] K. Tamura,et al. Endothelial Healing in Vein Grafts: Proliferative Burst Unimpaired by Genetic Therapy of Neointimal Disease , 2002, Circulation.
[38] E. Corday,et al. Radiocardiography: A New Method for Studying the Blood Flow Through the Chambers of the Heart in Human Beings. , 1948, Science.
[39] W. Beierwaltes,et al. Myocardial scanning with rubidium-86. , 1962, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[40] C. Zarins,et al. Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.
[41] S. Vallabhajosula,et al. Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patients. , 1990, Arteriosclerosis.
[42] W D Wagner,et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Circulation.
[43] H. Schelbert,et al. Radiolabeled Acetate as a Tracer of Myocardial Tricarboxylic Acid Cycle Flux , 1988, Circulation research.
[44] M. Naghavi,et al. Thermography basket catheter: In vivo measurement of the temperature of atherosclerotic plaques for detection of vulnerable plaques , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[45] H. Strauss,et al. Detection of Monocyte Chemoattractant Protein-1 Receptor Expression in Experimental Atherosclerotic Lesions: An Autoradiographic Study , 2001, Circulation.
[46] A. Fischman,et al. Radionuclide imaging of experimental atherosclerosis with nonspecific polyclonal immunoglobulin G. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[47] M. Simons,et al. Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease. , 2003, Trends in cardiovascular medicine.
[48] A. Mangi,et al. Gene therapy for human bypass grafts , 2001, Annals of medicine.
[49] Friedell Hl,et al. A radioisotope method of visualization of blood pools. , 1958 .
[50] D E Kuhl,et al. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. , 1990, Journal of the American College of Cardiology.
[51] John L. Humm,et al. From PET detectors to PET scanners , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[52] V. Fuster,et al. Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[53] B. Zaret,et al. Noninvasive regional myocardial perfusion with radioactive potassium. Study of patients at rest, with exercise and during angina pectoris. , 1973, The New England journal of medicine.
[54] H. Sinzinger,et al. Nuclear medicine and atherosclerosis , 2004, European Journal of Nuclear Medicine.
[55] R. Davis,et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[56] W D Wagner,et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[57] R. Bing,et al. The use of positron emitter in the determination of coronary blood flow in man. , 1965, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[58] J. Viikari,et al. Coronary flow reserve in young men with familial combined hyperlipidemia. , 1999, Circulation.
[59] T. Lehtimäki,et al. Coronary Flow Reserve Is Reduced in Young Men With IDDM , 1998, Diabetes.
[60] S. Gordon,et al. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. , 1987, The Biochemical journal.
[61] H. C. Stary,et al. The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression. , 2001, The American journal of cardiology.
[62] K Walsh,et al. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. , 1996, Human gene therapy.
[63] R. Parker,et al. Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature. , 2003, Atherosclerosis.
[64] G S Johnston,et al. Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease. , 1977, The New England journal of medicine.